MrgprF Acts as a Tumor Suppressor in Cutaneous Melanoma by Restraining PI3K/Akt Signaling

Scientists identified that MrgprF, a MAS related GPR family member, was decreased in cutaneous melanoma (CM) tissues and cell lines due to hypermethylation of its promoter region, and showed that patients with CM expressing high levels of MrgprF exhibited an improved clinical outcome.